Though rosiglitazone, for example, has been shown to decrease edema following a hemorrhagic event (123), further studies are required to investigate PPARγ specifically in the context of cerebral edema as a result of an adjacent glioma. This evidence concerns the gene PPARG and central nervous system cancer.